Canada markets closed

CARISMA Therapeutics Inc (W2J.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
1.4650+0.0300 (+2.09%)
At close: 07:26PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
14,919
14,919
9,834
0
0
Operating Expenses
Research Development
74,125
74,125
56,618
34,387
23,292
Selling General and Administrative
29,525
29,525
9,378
6,407
5,086
Total Operating Expenses
103,650
103,650
65,996
40,794
28,378
Operating Income or Loss
-88,731
-88,731
-56,162
-40,794
-28,378
Interest Expense
-
-
3,145
-
-
Total Other Income/Expenses Net
-84
-84
-1,919
-
-
Income Before Tax
-86,879
-86,879
-61,226
-40,784
-28,349
Income from Continuing Operations
-86,879
-86,879
-61,226
-40,784
-28,349
Net Income
-86,879
-86,879
-61,226
-40,784
-28,349
Net Income available to common shareholders
-86,879
-86,879
-61,226
-40,784
-28,349
Basic EPS
-1.21
-2.59
-1.52
-1.01
-0.70
Diluted EPS
-1.21
-2.59
-1.52
-1.01
-0.70
Basic Average Shares
40,255
33,524
40,255
40,255
40,255
Diluted Average Shares
40,255
33,524
40,255
40,255
40,255